Ascendis Pharma Oncology Division A/S
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ascendis Pharma Oncology Division A/S.The latest application filed is for "anti-ctla4 conjugates".
- Ascendis Pharma Oncology Division A/S - Hellerup DK
| Patent | Date |
|---|---|
| Anti-ctla4 Conjugates App 20220305136 - KNAPPE; Thomas ; et al. | 2022-09-29 |
| Conjugates Of Pattern Recognition Receptor Agonists App 20220062273 - SPROGOE; Kennett ; et al. | 2022-03-03 |
| Induction Of Sustained Local Inflammation App 20220054477 - ROSEN; David B. ; et al. | 2022-02-24 |
| Minimization Of Systemic Inflammation App 20220054478 - ROSEN; David B. ; et al. | 2022-02-24 |
| Sustained Local Drug Levels For Innate Immune Agonists App 20220054476 - ROSEN; David B. ; et al. | 2022-02-24 |
| IL-2 Conjugates App 20210024602 - Sprogoe; Kennett ; et al. | 2021-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 